Start for free
Start for free
David R. Walt logo

David R. Walt

North America, Massachusetts, United States, Boston

Description

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, an...

Investor Profile

David R. Walt has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (29%)
  • Series B (29%)
  • Seed (29%)
  • Series A (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Life Science
  • Therapeutics
  • Health Care
  • Medical
  • Big Data
  • Database
  • Chemical
  • Nanotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does David R. Walt frequently co-invest with?

Pura Vida Investments
Pura Vida Investments
North America, New York, United States, New York
Co-Investments: 1
Rathmann Family Foundation
Co-Investments: 1
Novalis LifeSciences
Novalis LifeSciences
North America, Virginia, United States, Hampton
Co-Investments: 1
Northpond Ventures
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
AB
Abbott Biotech Ventures
North America, Illinois, United States, Lake Forest
Co-Investments: 1
Illumina Ventures
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 2
AbbVie Biotech Ventures
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 1
Tempus
Tempus
North America, Illinois, United States, Chicago
Co-Investments: 1
KS
Katalyst Securities
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does David R. Walt often collaborate with?

PG
Patrick G. Ryan
North America, Illinois, United States, Chicago
Shared Deals: 1
AA
Aristides A. N. Patrinos
North America, Maryland, United States, Rockville
Shared Deals: 1
ES
Eric Schmidt
North America, California, United States, Mountain View
Shared Deals: 1
BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 1
JT
Shared Deals: 1
PR
Patrick Ryan
North America, Colorado, United States, Denver
Shared Deals: 1
Craig Mundie
Shared Deals: 3
HE
Hugh Evans
North America, Maryland, United States, Baltimore
Shared Deals: 1
MT
Mark Tompkins
North America, New York, United States, New York
Shared Deals: 1
EL
Eric Lefkofsky
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by David R. Walt?

Torus Biosystems

Cambridge, Massachusetts, United States

Torus Biosystems is a biotech startup that delivers molecular diagnostics for infectious diseases.

BiotechnologyHealth CareMedicalTest and Measurement
Series AMay 26, 2021
Amount Raised: $25,000,000
Vizgen

Cambridge, Massachusetts, United States

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

BiotechnologyHealth CareLife ScienceMedical
Series BApr 7, 2021
Amount Raised: $37,000,000
Stoicheia

Skokie, Illinois, United States

Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome.

BiotechnologyChemicalLife ScienceNanotechnology
SeedJan 27, 2019
Amount Raised: $5,000,000
LunaDNA

San Diego, California, United States

LunaDNA provides health and dna research platform owned by its community.

Big DataBiotechnologyDatabaseGenetics
Series UnknownMay 9, 2018
Amount Raised: $2,000,000
LunaDNA

San Diego, California, United States

LunaDNA provides health and dna research platform owned by its community.

Big DataBiotechnologyDatabaseGenetics
SeedDec 18, 2017
Amount Raised: $2,000,000
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series UnknownSep 27, 2017
Amount Raised: $20,000,000
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series BDec 21, 2011
Amount Raised: $5,400,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator